Boston biotech firm is making its discovery and production service available to firms working on diagnostics, treatments, and vaccines

NO₂ levels have fallen sharply in northern Italy and China

The novel virus is one of the easiest virus types to deactivate, though SARS-CoV-2-specific data are lacking

Companies are making their machines and expertise available to hospitals in need of parts

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for the virus causing COVID-19

Chemistry CROs are back in business as rest of world starts to lock down

Companies are making their machines and expertise available to hospitals in need of parts

Medicinal chemists focus on the main protease of SARS-CoV-2 to develop antiviral treatments for COVID-19

The National Institutes of Health receives the vast majority of the support

Activists say broad lack of enforcement threatens safety

Auto manufacturing is the first sector to halt demand for chemicals

These biomolecules could hold clues to why the virus is so infectious and to how to stop it

Activists say broad lack of enforcement threatens safety

The National Institutes of Health receives the vast majority of the support

Trafficked scaly anteaters found to carry coronaviruses related to SARS-CoV-2

As gene-based vaccines are being designed and tested at unprecedented speeds to fight COVID-19, scientists wonder if this will be the technology's make-or-break moment.

Delayed postdoc opportunities. Canceled commencement. Graduate students in chemistry describe how the COVID-19 pandemic has affected their work and lives

With university labs shuttered by COVID-19, chemistry faculty are getting a crash course in how to stay productive

Thought leaders in life sciences weigh in on lessons learned amid the COVID-19 pandemic

Scientists look to convalescent plasma, hyperimmune therapy, and monoclonal antibodies to treat COVID-19

Variables in fabrics, fit, and user behavior can influence how well a mask might block the virus's spread

Mauro Ferrari quits after three months at the helm

Structural data on the complex could guide drug and vaccine design

Variables in fabrics, fit, and user behavior can influence how well a mask might block the virus's spread

Work continues on chemical risks, climate, and what data regulators may consider

A new generation of technologies being used for the diagnosis, treatment, and prevention of COVID-19 will be pressure tested amid a pandemic

Industries press pause on steep growth trajectory

Gilead's Chief Medical Officer talks about the challenges of clinical design in the time of COVID-19

Cats can transmit SARS-CoV-2 to one another, but the virus replicates poorly in dogs, pigs, chickens, and ducks, study finds

These biomolecules could hold clues to why the virus is so infectious and how to stop it

As wipes and sprays sell out, quaternary ammonium compound makers try to keep up

Viral levels higher than expected based on confirmed COVID-19 cases

Most of the recently reported viral structures have left out the carbohydrate decorations that help mask the proteins from our immune system

Cats can transmit SARS-CoV-2 to one another, but the virus replicates poorly in dogs, pigs, chickens, and ducks, study finds

Manufacturing experts weigh in on Gilead's challenge in making its potential COVID-19 treatment

Manufacturing experts weigh in on Gilead's challenge in making its potential COVID-19 treatment

Most of the recently reported viral structures have left out the carbohydrate decorations that help mask the proteins from our immune system

With protective equipment in short supply, health-care facilities are decontaminating and reusing items designed to be disposable

Two studies pinpoint nasal cells and others that express the molecules the virus uses to get inside

Manufacturing shutdowns and oil prices were a drag on results

<i>Stereo Chemistry</i> looks at lessons learned from previous epidemics and the global effort underway to stop this new microscopic foe

Program boosts effort by the mRNA therapy pioneer to be first with a coronavirus vaccine

Behind the scenes, companies including Novartis, Takeda, and Gilead are collaborating in a loose alliance. Their work might not be done in time to stop COVID-19, but they hope it can prevent the next pandemic

Scientists detail the steps they took to determine the structures of SARS-CoV-2's proteins and the next steps toward COVID-19 treatments

With protective equipment in short supply, health-care facilities are decontaminating and reusing items designed to be disposable